GlaxoSmithKline (GSK)

See the following -

2D Barcodes Can Save Money And Streamline EHR Implementation

Katie Wike | Healthcare Technology Online | August 13, 2013

The use of 2D barcodes for vaccines improves the accuracy of medical records and transfers patient information directly into an EHR system; providing healthcare savings is the next step Read More »

Across Pharma, Few Open Arms For Trial Data Sharing

Alex Philippidis | Genetic Engineering & Biotechnology News (GEN) | July 9, 2013

Industry inches toward consensus on limited sharing as EMA, GSK press for open access. Read More »

Advancing Antimalarial Drug Research Through Open Source Initiatives

Jeremy Burrows | The Guardian | July 24, 2013

Open research can lead to new drugs tackling diseases that afflict the world's poor. But first, more scientists need to buy into contributing to something bigger than their careers Read More »

Apple Watch Leaves Patients Connected with Nowhere To Go

The highly anticipated unveiling of the Apple Watch Series 4 caused a news and social media sensation. Apple coined the iconic timepiece as the "guardian of your health", with health tracking functionalities such as the ability to detect atrial fibrillation (AFib) by a self-performed electrocardiogram (ECG). But from patients' and carepartners' perspectives, there is a long road to a universally accessible, seamlessly implemented, mass-adoption, and meaningful use for this wearable technology...Unfortunately, the vast majority of concerns in the public domain haven't emphasized the risks to health due to poor implementation, integration, and adoption strategies of digital tools and wearables.

Read More »

Big Pharma 'Overcharging' Poor Countries For Child Vaccines - Report

Staff Writer | RT News | January 21, 2015

Doctors Without Borders has released a new report blasting two top pharmaceutical companies for inflated costs of vital vaccines that have proved too steep for poor nations, recommending they adjust prices in order to save lives...

Read More »

Can Doctors Teach The Body To Cure Cancer?

Jacoba Urist | The Atlantic | July 28, 2014

Increasingly, doctors are using their patients' own immune systems as valuable weapons against the disease...

Read More »

Controlled Substances Compliance Expert Community Established

Press Release | Pistoia Alliance | August 11, 2014

The Pistoia Alliance Controlled Substances Compliance Services (CSCS) project has made it significantly easier for life science companies to comply with controlled substance legislation by establishing an expert community to interpret the often-ambiguous rules. Read More »

DIA 2014 50th Annual Meeting To Highlight TransCelerate BioPharma Collaboration

Press Release | DIA, TransCelerate | May 6, 2014

Industry leaders in R&D will examine accomplishments, progress and 2014 line extensions.  Susan Cantrell, senior vice president and managing director for DIA Americas, will chair the panel discussion “Collaboration in R&D: What’s New for TransCelerate BioPharma?” during DIA’s 2014 50th Annual Meeting at the San Diego Convention Center from June 15 to 19...

Read More »

Doctors' Dubious Excuses For Taking Pharmaceutical Companies' Money

Roy M. Poses | Health Care Renewal | March 19, 2013

Pro Publica has updated their database of payments by pharmaceutical payments to physicians and organizations.  It now has data from 15 companies totaling more than $2 billion from 2009 to 2012. To accompany Pro Publica's report, a number of news outlets wrote about payments given to local or regional doctors... Read More »

Dollars For Docs Mints A Millionaire

Tracy Weber and Charles Ornstein | ProPublica | March 11, 2013

Dr. Jon W. Draud, the medical director of psychiatric and addiction medicine at two Tennessee hospitals, pursues some eclectic passions. He’s bred sleek Basenji hunting dogs for show. And last summer, the Tennessee State Museum featured “African Art: The Collection of Jon Draud.” Read More »

GSK Expands Open-Source Research Project In TB

Staff Writer | PMLIVE | October 11, 2012

GlaxoSmithKline (GSK) has screened its entire pharmaceutical compound library of more two million compounds and identified about 200 hits with potential against tuberculosis (TB), which it will make available to external research teams as part of its drive towards an 'open innovation' approach to R&D. Read More »

Help Us Crowdsource Vaccine Prices Around The World

Carla Kweifio-Okai | The Guardian | January 20, 2015

Médecins sans Frontières is calling for the cost of the life-saving pneumococcal vaccine to be slashed, as it has become prohibitively expensive for poorer countries. Tell us how much it is costing you...

Read More »

Here's Why Africa's Ebola Epidemic Is Officially 'Spiraling Out of Control'

Tom McKay | World.Mic | September 2, 2014

Health authorities admitted Tuesday that the West African Ebola virus epidemic is accelerating quickly and may soon outpace the ability of medical teams to contain it. Meanwhile, the grim situation is being made worse by a massive strike among Liberian health care workers, who have accumulated large amounts of unpaid wages while suffering from overwork and the constant risk of exposure...

Read More »

In Stunning Win For Open Science, Johnson & Johnson Decides To Release Its Clinical Trial Data To Researchers

Matthew Herper | Forbes Magazine | January 30, 2014

Today, Johnson & Johnson JNJ +0.07% is taking a major step toward changing that, not only for drugs like the blood thinner Xarelto or prostate cancer pill Zytiga but also for the artificial hips and knees made for its orthopedics division or even consumer products. “You want to know about Listerine trials? They’ll have it,” says Harlan Krumholz of Yale University, who is overseeing the group that will release the data to researchers.

Read More »

International Team of Scientists Open Sources Search for Malaria Cure

The Open Source Malaria (OSM) project operates along very similar lines to traditional medicinal chemistry projects in that the team is looking for an antimalarial drug candidate suitable for Phase 1 clinical trials. However, the day to day running of the project works quite differently and is probably most clearly defined by the team’s commitment to The Six Laws of Open Science... Read More »